Despite the rise of biologics, corticosteroids remain a vital and cost-effective first-line treatment in the CIDP market, particularly in regions with limited access to expensive immunoglobulins. Medications like prednisone are widely used to reduce inflammation and alter the immune response, offering a high initial success rate for many newly diagnosed patients. For more data on drug-based...